Avecillas Jaime F, Mazzone Peter, Arroliga Alejandro C
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Clin Chest Med. 2003 Dec;24(4):645-69. doi: 10.1016/s0272-5231(03)00099-6.
Critically ill patients are at increased risk of acquiring nosocomial infections. A thorough clinical evaluation and the selection of appropriate diagnostic techniques are important elements in the evaluation of these patients. Nonetheless, this selection process can be difficult because of the wide spectrum of disease that is seen in the ICU and the lack of standardized studies that have evaluated the different diagnostic methods that are available. Many different antimicrobials are available for the treatment of ICU-acquired infections. Most antimicrobial regimens have not been evaluated in large-scale, prospective, randomized trials. Until this information is available, the clinician must make an effort to be familiar with the different clinical and epidemiologic variables that can be used to stratify patients at the moment of selecting antimicrobial therapy. The information provided in this article, used in association with good clinical judgment, will help the critical care physician provide optimal initial management of the infected patient in the ICU.
重症患者获得医院感染的风险增加。全面的临床评估和选择合适的诊断技术是评估这些患者的重要因素。尽管如此,由于重症监护病房(ICU)中所见疾病谱广泛,且缺乏评估现有不同诊断方法的标准化研究,这一选择过程可能会很困难。有许多不同的抗菌药物可用于治疗ICU获得性感染。大多数抗菌治疗方案尚未在大规模、前瞻性、随机试验中进行评估。在获得这些信息之前,临床医生必须努力熟悉在选择抗菌治疗时可用于对患者进行分层的不同临床和流行病学变量。本文提供的信息,结合良好的临床判断,将有助于重症监护医生为ICU中的感染患者提供最佳的初始管理。